본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

초록보기

Purpose The TRIUMPH trial was a biomarker-driven umbrella trial for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). This analysis focuses on the PIK3CAα (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) inhibitor alpelisib (arm 1) in patients with phosphoinositide 3-kinase (PI3K) pathway alterations.Materials and Methods Patients with PI3K pathway altered tumors were enrolled in the alpelisib arm of the TRIUMPH study. We conducted a detailed analysis of the correlation between PI3K pathway mutations and treatment outcomes including disease control rate, overall survival (OS), and progression-free survival (PFS).Results From October 2017 and August 2020, 203 were enrolled, with 42 treated with alpelisib. Response evaluation was possible for 33 patients. Genomic profiles revealed PIK3CA amplifications in 26.2%, and point mutations in E542K (26.2%), E545K (23.8%), and H1047R (9.5%). Neither PIK3CA amplification nor co-occurring TP53 mutations had a notable influence on alpelisib response or survival outcomes. Although the overall response rates were similar between helical domain mutations (E542, E545) and kinase domain mutation (H1047), patients with H1047 mutation exhibited significantly poorer PFS compared to those with non-H1047 PIK3CA alterations (1.6 vs. 7.3 months, p=0.017). OS in patients with H1047 kinase domain mutation showed a trend toward being shorter compared to others, though this difference did not reach statistical significance.Conclusion Alpelisib showed differential efficacy based on PI3K pathway alterations in patients with R/M HNSCC and was well-tolerated. These findings suggest the usefulness of next-generation sequencing testing-based decision-making when using the targeted agents in R/M HNSCC. We need to confirm results in larger cohorts.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
Advances in T-cell–directed immunotherapy for adult mature B-cell lymphoma : a comprehensive review of CAR T-cell and bispecific antibody therapies Jinchul Kim, Seok Jin Kim p. 905-922
Presentation of benefits and harms in cancer screening guidelines for Koreans : a systematic review Mi Ah Han, Hunju Lee, Kwangmin Kim, Seong Jung Kim, Eu Chang Hwang, Jae Hung Jung p. 923-931
Epidermal growth factor receptor aberrations identified by next-generation sequencing in patients with metastatic cancers Minkyue Shin, Dae-Ho Choi, Jaeyun Jung, Deok Geun Kim, Minae An, Sung Hee Lim, Seung Tae Kim, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Kyoung-Mee Kim, Jeeyun Lee p. 932-941
Significant dissatisfaction with an outdated system : a survey on the experience of application for off-label use of anti-cancer drugs by the Korean Society of Medical Oncology Jae Lyun Lee, Dong-Hoe Koo, Young-Woong Won, Young Saing Kim, Hee Kyung Ahn, Seungtaek Lim p. 942-950
CYBC1 drives glioblastoma progression via reactive oxygen species and NF-κB pathways Hyeon Ji Kim, Tae-Jun Kim, Jin-Hwa Cho, Mee-Seon Kim, Jin-Seok Byun, Do-Yeon Kim p. 951-967
Differential efficacy of alpelisib by PIK3CA mutation site in head and neck squamous cell carcinoma : an analysis from the KCSG HN 15-16 TRIUMPH trial Kyoo Hyun Kim, Shinwon Hwang, Min Kyoung Kim, Keon-Uk Park, Tak Yun, Keun-Wook Lee, Joo Hang Kim, Bhumsuk Keam, Byoung Chul Cho, So Yeon Oh, Sang Hee Cho, Sangwoo Kim, Sung-Bae Kim, Min Hee Hong, Hye Ryun Kim p. 968-980
Long-term survival outcomes of surgical resection for lung adenocarcinoma with intraoperatively diagnosed pleural metastasis : target treatment era Yelee Kwon, Jae Kwang Yun, Geun Dong Lee, Se Hoon Choi, Yong-Hee Kim, Hyeong Ryul Kim p. 981-988
Factors associated with smoking cessation of participants in the national lung cancer screening program in Korea Na-Young Yoon, Minji Seo, Nayoung Lee, Yeol Kim p. 989-999
Lipid metabolism related gene ACSL3 as a biomarker for predicting immunotherapy outcomes in lung adenocarcinoma Taiping He, Jinhan Hu, Haoyue Guo, Meng Diao, Yuanyuan Wang, Yuhan Wu, Lei Cheng, Chao Zhao, Xuefei Li, Caicun Zhou p. 1000-1018
Tracing metastatic evolutionary patterns in lung adenocarcinoma : prognostic dissection based on a multi-state model Geewon Lee, Yang-Jin Kim, Insuk Sohn, Jong Hoon Kim, Ho Yun Lee p. 1019-1029
Association between antipsychotic drug and survival in patients with lung cancer treated with chemoradiotherapy : a nationwide Korean cohort study Dong-Yun Kim, In Gyu Hwang, Sun Mi Kim, Dae Ryong Kang, Tae-Hwa Go, Se Hwa Hong, Shin Young Park, Hyunho Lee, Jin Hwa Choi p. 1030-1039
(The) synergistic effect of PARP inhibitors and irinotecan in small cell lung cancer cells Songji Oh, Soyeon Kim, Bhumsuk Keam, Jeonghwan Youk, Tae Min Kim, Dong-Wan Kim, Miso Kim p. 1040-1050
Novel breast cancer risk assessment tools for pre- and postmenopausal Asian women : development and validation in a nationwide mammographic screening cohort Wonyoung Jung, Yong-Moon Mark Park, Sang Hyun Park, Kyungdo Han, Junhee Park, Yohwan Yeo, Jung Kwon Lee, Dale P. Sandler, Dong Wook Shin p. 1051-1063
ALYREF-mediated regulation of TBL1XR1 and KMT2E synergistically upregulates APOC1, contributing to oxaliplatin resistance in esophageal cancer Jie Hu, Qilong Liu, Bi Feng, Yanling Lu, Kai Chen p. 1064-1089
Sex-specific molecular markers NRF2 and PD-L1 in colon carcinogenesis : implications for right-sided colon cancer Chin-Hee Song, Yonghoon Choi, Nayoung Kim, Ryoung Hee Nam, Jin Won Kim, Jae Young Jang, Eun Hye Kim, Sungchan Ha, Ha-Na Lee p. 1090-1103
Clinical characteristics of and treatment pattern for EGFR-amplified colorectal cancer Seong-Eun Kim, Hyehyun Jeong, Sun Young Kim, Jeong Eun Kim, Yong Sang Hong, Deokhoon Kim, Jihun Kim, Ji Sung Lee, Tae Won Kim p. 1104-1114
(The) roles of ninjurin1 and estrogen in modulating azoxymethane/dextran sodium sulfate–induced colitis-associated colorectal cancer in male mice Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Jae Young Jang, Eun Hye Kim, Sungchan Ha, Eun Shin, Ha-Na Lee, Hoon Choi, Kyu-Won Kim, Sejin Jeon, Goo Taeg Oh p. 1115-1134
Stereotactic ablative radiotherapy versus surgery in patients with pulmonary metastases from colorectal cancer Byung Min Lee, Ha Eun Kim, Young Ho Yang, Seung Yoon Yang, Han Sang Kim, Seo Hee Choi, Woong Sub Koom, Byung Jo Park, Jee Suk Chang p. 1135-1143
Evaluation of nomenclature of fatty liver disease in association with hepatocellular carcinoma : a 14.5-year cohort study in Korea Tung Hoang, Jeonghee Lee, Bo Hyun Kim, Yuri Cho, Jeongseon Kim p. 1144-1155
Preoperative prediction model for early recurrence of intrahepatic cholangiocarcinoma after surgical resection : development and external validation study Dong Hwan Kim, Sang Hyun Choi, Sehee Kim, Hyungjin Rhee, Eun-Suk Cho, Suk-Keu Yeom, Sumi Park, Seung Soo Lee, Mi-Suk Park p. 1156-1166
Pemetrexed maintenance versus observation in patients with advanced urothelial carcinoma who completed first-line platinum-based chemotherapy without disease progression (PREMIER, KCSG GU16-05) Inkeun Park, Shinkyo Yoon, Ilhwan Kim, Kwonoh Park, Suee Lee, Bhumsuk Keam, Joo-Hwan Park, Jin Young Kim, Yoon Ji Choi, Byeong Seok Sohn, Jae Lyun Lee p. 1167-1177
Dose-response association between alcohol consumption and kidney cancer risk differs according to glycemic status : a nationwide cohort study of 9.4 million individuals Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Jay J. Shen, Se Hoon Park p. 1178-1186
Validation of 2023 FIGO stage IA1-IIIC2 endometrial carcinoma : a retrospective analysis of two tertiary centers in South Korea and Taiwan Myeong-Seon Kim, Yen-Ling Lai, Yurimi Lee, Hyun-Soo Kim, Yu-Li Chen, Yoo-Young Lee p. 1187-1197
Prognostic value of POST-treatment extent of tumor (POSTTEXT) system in patients with hepatoblastoma Hana Jeong, Hee Mang Yoon, Pyeong Hwa Kim, Ah Young Jung, Young Ah Cho, Jin Seong Lee, Kyung-Nam Koh, Jung-Man Namgoong p. 1198-1206
Literature-guided 6-gene signature for the stratification of high-risk acute myeloid leukemia Jong Keon Song, Dong Hyeok Lee, Hyery Kim, Sang-Hyun Hwang p. 1207-1217
Outcomes of stereotactic body radiation therapy for large uveal melanoma : a retrospective analysis of Asian population Jong Won Park, Seowoong Jun, Ki Chang Keum, Christopher Seungkyu Lee, Kyung Hwan Kim p. 1218-1230
(A) prospective, single-cohort, open, multi-center, observational study of sublingual fentanyl for breakthrough cancer pain : effectiveness, safety, and tolerability in Korean cancer patients Youn Seon Choi, Su-Jin Koh, Woo Kyun Bae, Se Hyung Kim, Seong Hoon Shin, So Yeon Oh, Sang Byung Bae, Yaewon Yang, Eun-Kee Song, Yoon Young Cho, Pyung Bok Lee, Ho-Suk Oh, MinYoung Lee, Jin Seok Ahn p. 1231-1239